Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet.
Animals
Bifidobacterium
/ growth & development
Diabetes Mellitus, Type 2
/ complications
Diet, High-Fat
/ adverse effects
Dysbiosis
/ etiology
Female
Gastrointestinal Microbiome
Gastrointestinal Motility
Insulin Resistance
Intestinal Pseudo-Obstruction
/ etiology
Intestines
/ innervation
Lactobacillus
/ growth & development
Male
Mice
Mice, Inbred C57BL
Sex Factors
Diabetes mellitus
Diabetic enteric neuropathy
Enteric nervous system
Gastrointestinal motility
Gut microbiota
Journal
Cell and tissue research
ISSN: 1432-0878
Titre abrégé: Cell Tissue Res
Pays: Germany
ID NLM: 0417625
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
14
12
2018
accepted:
30
01
2019
pubmed:
20
2
2019
medline:
17
8
2019
entrez:
20
2
2019
Statut:
ppublish
Résumé
Diabetic patients suffer from gastrointestinal disorders associated with dysmotility, enteric neuropathy and dysbiosis of gut microbiota; however, gender differences are not fully known. Previous studies have shown that a high-fat diet (HFD) causes type two diabetes (T2D) in male mice after 4-8 weeks but only does so in female mice after 16 weeks. This study seeks to determine whether sex influences the development of intestinal dysmotility, enteric neuropathy and dysbiosis in mice fed HFD. We fed 8-week-old C57BL6 male and female mice a standard chow diet (SCD) or a 72% kcal HFD for 8 weeks. We analyzed the associations between sex and intestinal dysmotility, neuropathy and dysbiosis using motility assays, immunohistochemistry and next-generation sequencing. HFD ingestion caused obesity, glucose intolerance and insulin resistance in male but not female mice. However, HFD ingestion slowed intestinal propulsive motility in both male and female mice. This was associated with decreased inhibitory neuromuscular transmission, loss of myenteric inhibitory motor neurons and axonal swelling and loss of cytoskeletal filaments. HFD induced dysbiosis and changed the abundance of specific bacteria, especially Allobaculum, Bifidobacterium and Lactobacillus, which correlated with dysmotility and neuropathy. Female mice had higher immunoreactivity and numbers of myenteric inhibitory motor neurons, matching larger amplitudes of inhibitory junction potentials. This study suggests that sex influences the development of HFD-induced metabolic syndrome but dysmotility, neuropathy and dysbiosis occur independent of sex and prior to T2D conditions. Gastrointestinal dysmotility, neuropathy and dysbiosis might play a crucial role in the pathophysiology of T2D in humans irrespective of sex.
Identifiants
pubmed: 30778729
doi: 10.1007/s00441-019-03002-0
pii: 10.1007/s00441-019-03002-0
pmc: PMC6541020
mid: NIHMS1522040
doi:
Types de publication
Journal Article
Langues
eng
Pagination
325-340Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM103408
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM103324
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30GM103324
Pays : United States
Références
Annu Rev Physiol. 1999;61:117-42
pubmed: 10099684
J Physiol. 2001 Sep 1;535(Pt 2):565-78
pubmed: 11533145
Endocr J. 2002 Aug;49(4):503-9
pubmed: 12402983
J Hypertens. 2004 Jan;22(1):11-9
pubmed: 15106785
Endocr Rev. 2004 Aug;25(4):612-28
pubmed: 15294884
Diabetes. 2005 May;54(5):1528-33
pubmed: 15855342
Diabetes Care. 2005 Nov;28(11):2745-9
pubmed: 16249550
Nat Med. 2006 Jan;12(1):75-80
pubmed: 16397575
J Clin Invest. 2006 Feb;116(2):344-56
pubmed: 16453021
Anaerobe. 2004 Oct;10(5):301-7
pubmed: 16701531
ILAR J. 2006;47(3):186-98
pubmed: 16804194
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Diabetes. 2007 Jul;56(7):1761-72
pubmed: 17456850
Neurogastroenterol Motil. 2007 Dec;19(12):951-60
pubmed: 17971027
BMC Gastroenterol. 2008 May 30;8:21
pubmed: 18513423
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Neurogastroenterol Motil. 2010 Dec;22(12):1332-9
pubmed: 20718943
Neurogastroenterol Motil. 2011 Feb;23(2):131-8, e26
pubmed: 20939847
Endocrinology. 2011 Jan;152(1):36-47
pubmed: 21068163
J Vis Exp. 2010 Dec 01;(46):null
pubmed: 21189461
Gastroenterology. 2011 May;140(5):1575-85.e8
pubmed: 21300066
J Neurogastroenterol Motil. 2011 Apr;17(2):140-7
pubmed: 21602990
Front Physiol. 2011 Dec 07;2:94
pubmed: 22162969
Biochem Cell Biol. 2012 Apr;90(2):124-41
pubmed: 22221155
Nat Rev Gastroenterol Hepatol. 2012 Mar 06;9(5):286-94
pubmed: 22392290
PLoS One. 2012;7(3):e33865
pubmed: 22457796
FEMS Microbiol Ecol. 2013 Feb;83(2):299-309
pubmed: 22909308
PLoS One. 2012;7(9):e46057
pubmed: 23049932
Nutr Diabetes. 2011 Jul 18;1:e12
pubmed: 23154580
Neurogastroenterol Motil. 2013 Jan;25(1):4-15
pubmed: 23279728
Neurogastroenterol Motil. 2013 Mar;25(3):e205-14
pubmed: 23316914
Gastroenterology. 2013 May;144(5):967-77
pubmed: 23380084
J Physiol. 2013 Aug 1;591(15):3725-37
pubmed: 23732648
Cell Tissue Res. 2013 Nov;354(2):381-94
pubmed: 23881404
PLoS One. 2013 Dec 03;8(12):e81413
pubmed: 24312551
Neurogastroenterol Motil. 2014 Jan;26(1):98-107
pubmed: 24329946
Nutr Metab (Lond). 2014 Jan 07;11(1):3
pubmed: 24398016
Neurogastroenterol Motil. 2014 May;26(5):611-24
pubmed: 24661628
ISME J. 2014 Oct;8(10):2116-30
pubmed: 24694712
Int J Endocrinol. 2014;2014:674987
pubmed: 24883061
World J Gastroenterol. 2014 Jun 14;20(22):6725-43
pubmed: 24944465
Neurogastroenterol Motil. 2014 Aug;26(8):1188-99
pubmed: 24952996
PLoS One. 2014 Jul 31;9(7):e103969
pubmed: 25080336
Cell Rep. 2014 Oct 23;9(2):633-45
pubmed: 25373903
Gastroenterol Clin North Am. 2015 Mar;44(1):31-8
pubmed: 25667021
Cell Tissue Res. 2015 Aug;361(2):411-26
pubmed: 25722087
Cell Metab. 2015 Sep 1;22(3):516-530
pubmed: 26299453
Exp Physiol. 2016 Jan;101(1):81-99
pubmed: 26381722
Genome Med. 2016 Apr 20;8(1):42
pubmed: 27098727
PLoS One. 2016 May 26;11(5):e0154090
pubmed: 27228093
Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1;311(2):G210-20
pubmed: 27288421
J Physiol. 2017 Mar 1;595(5):1831-1846
pubmed: 28000223
J Physiol. 2017 Mar 1;595(5):1441-1442
pubmed: 28078679
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):523-530
pubmed: 28786059
Am J Physiol Endocrinol Metab. 2018 Apr 1;314(4):E334-E352
pubmed: 28874357
Sci Rep. 2017 Sep 7;7(1):10776
pubmed: 28883460
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Intern Med. 1995 Apr;237(4):403-9
pubmed: 7714464
Gut. 1996 Aug;39(2):299-305
pubmed: 8977347